Aethlon Medical, Inc. (Nasdaq: AEMD) announced today that its researchers have completed in vitro studies that demonstrate the rapid capture ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE